Newsroom
Category
January 11, 2023
Statement from the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio about a timely topic in the news: The U.S. Food and Drug Administration on Friday, Jan. 6, 2023, approved lecanemab, a drug that targets the basic pathophysiology of Alzheimer’s disease. The FDA action is an “accelerated approval” of the […]
January 6, 2023
Researchers discover toxic process involving ‘jumping genes’ Scientists from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) today reported that an inflammatory trigger like one present during viral infections is elevated in Alzheimer’s disease and progressive supranuclear palsy, a rare brain disorder. “We have identified a new trigger of […]
January 5, 2023
Researchers report treatment for combat-related post-traumatic stress disorder, which affects hundreds of thousands of U.S. military personnel and veterans, can be both fast and effective for a majority of patients.
December 20, 2022
The Mays Cancer Center at UT Health San Antonio — South Texas’ only National Cancer Institute-Designated Cancer Center — is putting a decades-old antidepressant drug to new use treating breast cancers that don’t respond to existing therapies. Research in the Joe R. and Teresa Lozano Long School of Medicine at UT Health San Antonio provided […]
December 15, 2022
American Federation for Aging Research grant allows exploration of signaling molecules toxic in Alzheimer’s, diabetes, aging The American Federation for Aging Research (AFAR) selected Juan Pablo Palavicini, PhD, an early career scientist at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), to receive the 2022 Glenn Foundation for Medical […]
December 15, 2022
The Institute for Integration of Medicine & Science and the UTSA College for Health, Community and Policy are seeking proposals for one-year Community Engagement Small Project Grants. The goal is to promote, develop and expand community and academic research partnerships for the translation of science from basic discovery to clinical practice, to public health benefit. […]